A mix of guidance reductions, tariff challenges, and decreasing product momentum has resulted in a 56% decline in shares ...

In his latest research report, Top UBS analyst Karl Keirstead stated that following recent checks and debates, he remains “very constructive” on ...

Progyny's fundamentals remain strong with solid revenue growth, impressive cash flow, and a debt-free balance sheet despite recent share price weakness.

Despite bad press and a declining stock price, Intel generates $50 billion in annual revenue and maintains a healthy debt-to-equity ratio.

JPMorgan remains the strongest U.S. bank, with a safe balance sheet, high returns on equity, and a broad customer reach. Read ...

Even though these out-of-favor stocks might see their stock prices go lower and quiet for a little while, sometimes their fundamentals keep pushing higher under the radar and the broader ...

Stifel The analyst characterized the second quarter of 2025 as a “slight beat,” but emphasized that the company’s “fundamentals are still stuck in the mud.” Chan noted that, broadly, the ...

Palantir shares tumbled Tuesday afternoon, extending recent losses as a high-profile short seller fueled worries the stock ...

On that note, here is one healthcare stock boasting a durable advantage and two we’re swiping left on. With over 2.5 million ...

For stock investors, one way to prosperity on Monday was by having a position in medical tech company Waystar (NASDAQ: WAY).